HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation

被引:0
|
作者
Hsieh, Shih-Han [1 ,2 ]
Yu, Fu-Hsien [1 ,2 ]
Huang, Kuo-Jung [1 ]
Wang, Chin-Tien [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Hsinchu, Taiwan
关键词
HIV; retroviruses; reverse transcriptase; IMMUNODEFICIENCY-VIRUS TYPE-1; TRYPTOPHAN REPEAT MOTIF; DIMERIZATION; MATURATION; MUTATIONS; POLYPROTEIN; PR160(GAG-POL); PR160GAG-POL; EXPRESSION; INHIBITORS;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Proteolytic processing of human immunodeficiency virus type 1 particles mediated by viral protease (PR) is essential for acquiring virus infectivity. Activation of PR embedded in Gag-Pol is triggered by Gag-Pol dimerization during virus assembly. We previously reported that amino acid substitutions at the RT tryptophan repeat motif destabilize virus-associated RT and attenuate the ability of efavirenz (EFV, an RT dimerization enhancer) to increase PR-mediated Gag cleavage efficiency. Furthermore, a single amino acid change at RT significantly reduces virus yields due to enhanced Gag cleavage. These data raise the possibility of the RT domain contributing to PR activation by promoting Gag-Pol dimerization. To test this hypothesis, we investigated the putative involvement of a hydrophobic leucine repeat motif (LRM) spanning RT L282 to L310 in RT/RT interactions. We found that LRM amino acid substitutions led to RT instability and that RT is consequently susceptible to degradation by PR. The LRM mutants exhibited reduced Gag cleavage efficiencies while attenuating the EFV enhancement of Gag cleavage. In addition, an RT dimerization-defective mutant, W401A, reduced enhanced Gag cleavage via a leucine zipper (LZ) motif inserted at the deleted Gag-Pol region. Importantly, the presence of RT and integrase domains failed to counteract the LZ enhancement of Gag cleavage. A combination of the Gag cleavage enhancement factors EFV and W402A markedly impaired Gag cleavage, indicating a disruption of W402A Gag-Pol dimerization following EFV binding to W402A Gag-Pol. Our results support the idea that RT modulates PR activation by affecting Gag-Pol/Gag-Pol interaction.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation
    Hsieh, Shih-Han
    Yu, Fu-Hsien
    Huang, Kuo-Jung
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2023, 97 (09)
  • [2] HIV-1 Reverse Transcriptase Heterodimer Stability
    Kar, S. R.
    Lebowitz, J.
    Braswell, E.
    McPherson, S.
    Protein Engineering, 8
  • [3] HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
    Rhee, Soo-Yon
    Sankaran, Kris
    Varghese, Vici
    Winters, Mark A.
    Hurt, Christopher B.
    Eron, Joseph J.
    Parkin, Neil
    Holmes, Susan P.
    Holodniy, Mark
    Shafer, Robert W.
    JOURNAL OF VIROLOGY, 2016, 90 (13) : 6058 - 6070
  • [4] Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase
    Nguyen, Phuong D. M.
    Zheng, Jie
    Gremminger, Thomas J.
    Qiu, Liming
    Zhang, Dong
    Tuske, Steve
    Lange, Margaret J.
    Griffin, Patrick R.
    Arnold, Eddy
    Chen, Shi-Jie
    Zou, Xiaoqin
    Heng, Xiao
    Burke, Donald H.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (05) : 2709 - 2722
  • [5] HIV-1 REVERSE-TRANSCRIPTASE HETERODIMER STABILITY
    LEBOWITZ, J
    KAR, SR
    BRASWELL, E
    MCPHERSON, S
    RICHARD, D
    PROTEIN ENGINEERING, 1995, 8 : 118 - 118
  • [6] HIV-1 reverse transcriptase inhibitors
    El Safadi, Yazan
    Vivet-Boudou, Valerie
    Marquet, Roland
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (04) : 723 - 737
  • [7] HIV-1 reverse transcriptase inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 122
  • [8] HIV-1 reverse transcriptase inhibitors
    Yazan El Safadi
    Valérie Vivet-Boudou
    Roland Marquet
    Applied Microbiology and Biotechnology, 2007, 75 : 723 - 737
  • [9] Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability
    Figueiredo, Anna
    Zelina, Shannon
    Sluis-Cremer, Nicolas
    Tachedjian, Gilda
    CURRENT HIV RESEARCH, 2008, 6 (02) : 130 - 137
  • [10] Murine leukemia virus reverse transcriptase:: Structural comparison with HIV-1 reverse transcriptase
    Cote, Marie L.
    Roth, Monica J.
    VIRUS RESEARCH, 2008, 134 (1-2) : 186 - 202